San Diego-based molecular diagnostics company developing cancer tests, including the Breast Cancer Index for assessing recurrence risk and extended anti-estrogen therapy benefit, and Cancer Type ID for identifying the origin of cancers with uncertain diagnoses
San Diego-based molecular diagnostics company developing cancer tests, including the Breast Cancer Index for assessing recurrence risk and extended anti-estrogen therapy benefit, and Cancer Type ID for identifying the origin of cancers with uncertain diagnoses.